Androgen Deprivation Therapy Market is thriving worldwide by 2026 | Top Key Players like Bayer AG, Johnson & Johnson, Pfizer Inc., Astellas Pharma Inc., Novartis International AG, Veru Inc., Sanofi S.A., GlaxoSmithKline plc
Androgen deprivation therapy (ADT) is a type of antihormone therapy which is primarily utilized in the cure of prostate cancer. Prostate cancer cells typically requires androgen hormones such as testosterone to grow. The use of androgen deprivation therapy reduces the level of androgen hormones, with surgery or drug delivery to prevent the prostate cells from rising. Various studies have determined that ADT has shown the benefits in patients with metastatic disease, and as an addition to radiation therapy in patients with locally developed disease, including those with adverse intermediate-risk or extreme-risk localized disease.
Request a sample Report of Androgen Deprivation Therapy Market at: https://www.marketstudyreport.com/request-a-sample/2496581/?utm_source=OPR.com/&utm_medium=SP
Surging incidences of prostate cancer, rising male geriatric population, along with increasing government efforts to implement & conduct programs for creating of awareness of screening tests such as Prostate-Specific Antigen (PSA) blood tests are the few factor responsible for high CAGR of the market over the forecast period. For instance, according to the GLOBOCAN 2018 estimates in 2018, about 1,276,106 new cases of prostate cancer were registered worldwide, representing 7.1% of all cancers in men. Similarly, As per the Canadian Cancer Society, it is estimated that 22,900 men will be diagnosed with prostate cancer in 2019 and this represents 20% of all new cancer cases in men in 2019.
Moreover, technological advancement in screening & diagnostic tests is one of the major factor projected to create lucrative growth opportunities to the market growth in the forecasting years. However, side effects associated with ADT is the major factor restraining the growth of global Androgen Deprivation Therapy (ADT) market during the forecast period of 2019-2026.
Major market player included in this report are:
o Pfizer Inc.
o Astellas Pharma Inc.
o Johnson & Johnson
o Novartis International AG
o Veru Inc.
o Sanofi S.A.
o GlaxoSmithKline plc
o Bayer AG
o Orion Corporation
o AstraZeneca Plc.
The regional analysis of global Androgen Deprivation Therapy (ADT) Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging investments in R&D for the development of newer immunotherapies and targeted drug therapies to treat prostate cancer in the region.
However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period due to rising awareness among patient towards the treatment of prostate cancer. Further, increasing number of government programs to promote the adoption of ADT, would also create a lucrative opportunity for the growth of the market in the Asia-Pacific region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:
By Drug Class:
o LHRH Agonists
o LHRH Antagonist
By Route of Administration:
By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
Table of Contents:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Androgen Deprivation Therapy (ADT) Market, by Drug Class, 2017-2026 (USD Billion)
1.2.2. Androgen Deprivation Therapy (ADT) Market, by Route of Administration, 2017-2026 (USD Billion)
1.2.3. Androgen Deprivation Therapy (ADT) Market, by Distribution Channel, 2017-2026 (USD Billion)
1.2.4. Androgen Deprivation Therapy (ADT) Market, by Region, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Androgen Deprivation Therapy (ADT) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Androgen Deprivation Therapy (ADT) Market Dynamics
3.1. Androgen Deprivation Therapy (ADT) Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Androgen Deprivation Therapy (ADT) Market Analysis
Chapter 5. Global Androgen Deprivation Therapy (ADT) Market, by Drug Class
Chapter 6. Global Androgen Deprivation Therapy (ADT) Market, by Route of Administration
Chapter 7. Global Androgen Deprivation Therapy (ADT) Market, by Distribution Channel
Chapter 8. Global Androgen Deprivation Therapy (ADT) Market, Regional Analysis
Chapter 9. Androgen Deprivation Therapy Market Competitive Intelligence
Ask for Discount on Androgen Deprivation Therapy Market Report at: https://www.marketstudyreport.com/check-for-discount/2496581/?utm_source=OPR.com/&utm_medium=SP
Related Reports: https://www.marketwatch.com/press-release/smart-hospitals-market-share-historical-growth-analysis-opportunities-and-forecast-to-2025-2020-04-27
Market Study Report LLC,
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Androgen Deprivation Therapy Market is thriving worldwide by 2026 | Top Key Players like Bayer AG, Johnson & Johnson, Pfizer Inc., Astellas Pharma Inc., Novartis International AG, Veru Inc., Sanofi S.A., GlaxoSmithKline plc here
News-ID: 2026378 • Views: 3419
More Releases from marketstudyreport.com
Covid -19 Impact on Video Conferencing Market Size 2026: Top Companies, Trends a …
Market Study Report recently introduced new title on “2020-2026 Global Video Conferencing Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates Market size outlook and status to 2026. Video Conferencing Market size is anticipated to grow at over 19% CAGR between 2020 and 2026. The global video conferencing market is set to register a tremendous rise in its growth
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: https://www.marketstudyreport.com/request-a-sample/2679238/?utm_source=OPR.com/&utm_medium=SP The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides
More Releases for Androgen
Androgen deprivation therapy Market to Witness a Geometric Progression between 2 …
Androgen deprivation therapy is a hormone therapy of prostate cancer in males, by depriving the excess amount of androgen. Androgen is a sex hormone produced in the testes and adrenalin gland in the form of testosterone and dihydrotestosterone. According to the World Health Organization (WHO), prostate cancer is the fourth leading cancer, with 1.3 million global cases. Androgen deprivation therapy comprises the deprivation androgen to curb its detrimental effects such
Androgen Deprivation Therapy Market, Industry Share, Trends, Growth, Future Pros …
Androgen deprivation therapy (ADT), also known as androgen suppression therapy, is administered to men with prostate cancer. The pancreas can provide treatment for advanced and metastatic disease by providing ADT as an androgen-dependent organ. ADT is also used in conjunction with external beam radiation therapy (EBRT) to improve response to radiation in patients with moderate to high risk prostate cancer. It is estimated that about 40% of patients diagnosed with
Androgen Antagonist Market 2020 Covid-19 impact analysis– Tokai Pharmaceutical …
Androgen Antagonist -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Androgen Antagonist Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has
Androgen Deprivation Therapy (ADT) Market 2018 Unique Research Methodologies Wit …
Androgens are male sex hormones responsible for masculine characteristics such ad muscular build, deeper voice, and facial hair. Most of the androgens are produced in testes and their two most common types are dihydrotestosterone (DHT) and testosterone. Along with normal functions, androgens also contribute to prostate cancer cell growth, especially during early stages of the cancer. Androgen deprivation therapy, also called androgen suppression therapy, is used either to reduce the
Global (United States, European Union and China) Androgen Replacement Therapy Ma …
Market Research Report Store offers a latest published report on Androgen Replacement Therapy Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/621294/global-united-states-european-union-china In 2019, the market size of
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer …
Prostate cancer occurs when cells in prostate glands grow uncontrollably. Prostate is an exocrine gland that makes the fluid part of semen and lie below the bladder in front of the rectum. As per the National Institute of Health (NIH), 10.7% of all new cases of cancer in the U.S. are of prostate cancer. Download the sample report @ https://www.pharmaproff.com/request-sample/1137 Moreover, according to the National Cancer Institute, prostate cancer is the